A MULTICENTER, OPEN-LABEL STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFECT ON SEIZURES AND BEHAVIORAL SYMPTOMS OF RADIPRODIL IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) OR FOCAL CORTICAL DYSPLASIA (FCD) TYPE II
- Registry ID
- RAD-GRIN-201
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- GRIN THERAPEUTICS, INC
- Start date
- 2025-05-15
- Last update
- 2023-09-27
Conditions
- FOCAL CORTICAL DYSPLASIA (FCD)
- TUBEROUS SCLEROSIS COMPLEX (TSC)
View on source registry